Nisamox 500mg Tablet - per Tablet

Nisamox 500mg Tablet - per Tablet View larger

£ 1.34 inc. VAT

Nisamox 500 mg Tablets are an antibiotic used for treatment of the certain bacterial infections. VET PRESCRIPTION REQUIRED

More details


Data sheet

Target Animal:Dogs and Cats
Pet Prescription Required?:Yes (For UK Orders)
Product Name:Nisamox 500mg Tablet - per Tablet
Active Ingredient:Amoxicillin and Clavulanic acid
Pack Size:Sold Individually

More info

This medication may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase this item if you have or are in the process of arranging such a prescription. See information bar for further details.  

Nisamox Tablets are for oral administration to dogs. Each Nisamox 500 mg Tablet contains Amoxicillin 400 mg (as Amoxicillin Trihydrate) and Clavulanic Acid 100 mg (as Potassium Clavulanate).

Nisamox 500 mg Tablets are indicated for treatment of the following infections caused by �-lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid: �Skin infections (including superficial and deep pyodermas) caused by susceptible Staphylococci. �Urinary tract infections caused by susceptible Staphylococci or Escherichia coli. �Respiratory infections caused by susceptible Staphylococci. �Enteritis caused by susceptible Escherichia coli. It is recommended to carry out suitable tests for sensitivity testing when initiating the treatment. The treatment should only proceed if sensitivity is proven to the combination. In vitro potentiated amoxicillin is active against a wide range of clinically important aerobic and anaerobic bacteria including: Gram-positive: Staphylococci (including �-lactamase producing strains) Clostridia Streptococci Gram-negative: Escherichia coli (including most �-lactamase producing strains) Campylobacter spp Pasteurellae Proteus spp

Dosage and administration
Administration: By the oral route. The tablets may be crushed and added to a little food. Dosage rate: 12.5 mg combined actives/kg bodyweight twice daily. The recommended dose of 12.5 mg per kg bodyweight is equivalent to one 250 mg tablet per 20 kg bodyweight. Dosage frequency: The following table is intended as a guide to dispensing Nisamox 250 mg Tablets at the standard dose rate of 12.5 mg/kg twice daily.   Number of Tablets per dose twice daily Bodyweight 250 mg 19-20 1 21-30 1� 31-40 2 41-50 2� more than 50 3 Duration of therapy: Routine cases involving all indications: The majority of cases respond to between 5 and 7 days therapy. Chronic or refractory cases: In these cases where there is considerable tissue damage a longer course of therapy may be required in that it allows sufficient time for damaged tissue to repair.

Contra-indications warnings etc
For animal treatment only. Do not use in rabbits guinea pigs hamsters or gerbils. Do not use in animals with known hypersensitivity to penicillin or other substances of the beta-lactam group. Do not use in animals with serious dysfunction of the kidneys accompanied by anuria and oliguria. Do not use where resistance to this combination is known to occur. Hypersensitivity reactions unrelated to dose can occur with these agents. In case of allergic reaction the treatment should be withdrawn. Gastro-intestinal symptoms (diarrhoea vomiting) may occur after administration. Do not administer to horses and ruminating animals. Use during pregnancy and lactation: Use only according to the benefit/risk assessment by the responsible veterinarian. Operator Warnings Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection inhalation ingestion or skin contact. Hypersensitivity to penicillins may lead to cross-reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure taking all recommended precautions. If you develop symptoms following exposure such as a skin rash you should seek medical advice and show the doctor this warning. Swelling of the face lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention. Wash hands after use.   Pharmaceutical precautions Do not store above 25�C. Store in a dry place. Keep out of the reach of children. Dispose of any unused product in accordance with guidance from your local waste regulation authority.

Legal category
Nisamox is a POM-V